Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Endothelial-Mesenchymal Transition or Functional Tissue Regeneration - Two Outcomes of Heart Remodeling

B. Šalingová, Z. Červenák, A. Adamičková, N. Chomanicová, S. Valášková, A. Gažová, J. Kyselovič

. 2021 ; 70 (Suppl. 1) : S13-S20. [pub] 20211130

Language English Country Czech Republic

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc22009460

Heart remodeling occurs as a compensation mechanism for the massive loss of tissue during initial heart failure and the consequent inflammation process. During heart remodeling fibroblasts differentiate to myofibroblasts activate their secretion functions and produce elevated amounts, of extracellular matrix (ECM) proteins, mostly collagen, that form scar tissue and alter the normal degradation of ECM. Scar formation does replace the damaged tissue structurally; however, it impedes the normal contractive function of cardiomyocytes (CMs) and results in long-lasting effects after heart failure. Besides CMs and cardiac fibroblasts, endothelial cells (ECs) and circulating endothelial progenitor cells (cEPCs) contribute to heart repair. This review summarizes the current knowledge of EC-CM crosstalk in cardiac fibrosis (CF), the role of cEPCs in heart regeneration and the contribution of Endothelial-mesenchymal transition (EndoMT).

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22009460
003      
CZ-PrNML
005      
20250626150951.0
007      
ta
008      
220419s2021 xr a f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934780 $2 doi
035    __
$a (PubMed)34918525
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Šalingová, Barbara $u 5th Department of Internal Medicine, University Hospital Bratislava-Ružinov, Bratislava, Slovakia $7 xx0333146
245    10
$a Endothelial-Mesenchymal Transition or Functional Tissue Regeneration - Two Outcomes of Heart Remodeling / $c B. Šalingová, Z. Červenák, A. Adamičková, N. Chomanicová, S. Valášková, A. Gažová, J. Kyselovič
520    9_
$a Heart remodeling occurs as a compensation mechanism for the massive loss of tissue during initial heart failure and the consequent inflammation process. During heart remodeling fibroblasts differentiate to myofibroblasts activate their secretion functions and produce elevated amounts, of extracellular matrix (ECM) proteins, mostly collagen, that form scar tissue and alter the normal degradation of ECM. Scar formation does replace the damaged tissue structurally; however, it impedes the normal contractive function of cardiomyocytes (CMs) and results in long-lasting effects after heart failure. Besides CMs and cardiac fibroblasts, endothelial cells (ECs) and circulating endothelial progenitor cells (cEPCs) contribute to heart repair. This review summarizes the current knowledge of EC-CM crosstalk in cardiac fibrosis (CF), the role of cEPCs in heart regeneration and the contribution of Endothelial-mesenchymal transition (EndoMT).
650    12
$a transdiferenciace buněk $7 D054338
650    _2
$a endoteliální buňky $x fyziologie $7 D042783
650    _2
$a endoteliální progenitorové buňky $x fyziologie $7 D066026
650    _2
$a srdce $x fyziologie $7 D006321
650    _2
$a lidé $7 D006801
650    _2
$a kardiomyocyty $x fyziologie $7 D032383
650    _2
$a interakce mezi receptory a ligandy $7 D020239
650    12
$a regenerace $7 D012038
650    12
$a remodelace komor $7 D020257
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Červenák, Zdenko $7 xx0333145 $u 5th Department of Internal Medicine, University Hospital Bratislava-Ružinov, Bratislava, Slovakia
700    1_
$a Samáková, Adriana, $d 1993- $7 xx0267319 $u 5th Department of Internal Medicine, University Hospital Bratislava-Ružinov, Bratislava, Slovakia
700    1_
$a Sabová, Nikola, $d 1993- $7 xx0267320 $u Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University Bratislava, Slovakia
700    1_
$a Valášková, Simona, $d 1985- $7 xx0302182 $u Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University Bratislava, Slovakia
700    1_
$a Gažová, Andrea, $d 1980- $7 xx0255822 $u Institute of Pharmacology and Clinical Pharmacology, Comenius University Faculty of Medicine, Bratislava, Slovakia
700    1_
$a Kyselovič, Ján, $d 1963- $7 xx0082943 $u 5th Department of Internal Medicine, University Hospital Bratislava-Ružinov, Bratislava, Slovakia
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 70, Suppl. 1 (2021), s. S13-S20
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34918525 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20220419 $b ABA008
991    __
$a 20250626150945 $b ABA008
999    __
$a ok $b bmc $g 1796968 $s 1160658
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 70 $c Suppl. 1 $d S13-S20 $e 20211130 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK124 $a Pubmed-20220419

Find record

Citation metrics

Archiving options